Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression

NCT: NCT00590265 · COMPLETED

NCT IDNCT00590265
StatusCOMPLETED
Start Date2008-01
Completion2025-10-27
SponsorDouglas Mental Health University Institute (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the efficacy and safety of light therapy for the treatment of bipolar type II patients relapsing into a depressive phase during autumn or winter.

Frequently Asked Questions

What is Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression?

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression is a clinical trial registered under NCT00590265. Current status: COMPLETED.

What is the status of NCT00590265?

The current status of NCT00590265 (Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression) is: COMPLETED.

When did Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression start?

Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression started on 2008-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.